Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Pediatric Surgery International

Volumn 24, Issue 1, 2008, Pages 101-105

  Fiegel, Henning C ^a   Kaifi, Jussuf T ^b   Quaas, Alexander ^b   Varol, Emine ^b   Krickhahn, Annika ^b   Metzger, Roman ^a   Sauter, Guido ^b   Till, Holger ^a   Izbicki, Jakob R ^b   Erttmann, Rudolf ^b   Kluth, Dietrich ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Childhood cancer; Neuroblastoma; Thy1; Tumor marker

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; THY 1 ANTIGEN;

ANALYSIS OF VARIANCE; CHILD; CONFERENCE PAPER; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL SIGNIFICANCE; SURVIVAL; THYMUS; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ANTIGENS, THY-1; CHILD, PRESCHOOL; ELECTROPHORESIS, AGAR GEL; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; NEOPLASM STAGING; NEUROBLASTOMA; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 37749023040     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-007-2033-4     Document Type: Conference Paper

References (25)

1. Weinstein JL, Katzenstein HM, Cohn SL (2003) Advances in the diagnosis and treatment of neuroblastoma. Oncologist 8:278-292
2. Evans AE, Gerson J, Schnaufer L (1976) Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44:49-54
3. Haas D, Albin AR, Miller C (1988) Complete pathologic maturation and regression of IVS neuroblastoma without treatment. Cancer 62:818-825
4. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. NEJM 341:1165-1173
5. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477
6. Evans AE, D'Angio GJ, Propert K, Anderson J, Hann HW (1987) Prognostic factors in neuroblastoma. Cancer 59:1853-1859
7. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP et al. (1999) The international Neuroblastoma Pathology Classification. Cancer 86:364-372
8. Riley RD, Heney D, Jones DR, Sutton AJ, Lambert PC, Abrams KR, Young B, Wailoo AJ, Burchill SA (2004) A systematic review of molecular and biological markers in neuroblastoma. Clin Cancer Res 10:4-12
9. Fidler IJ (1992) Critical determinants of metastasis. Semin Cancer Biol 12:89-96
10. Williams AF, Gagnon J (1982) Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin. Science 216:696-703
11. Craig W, Kay R, Cutler RL, Landsdorp PM (1993) Expression of Thy1 on human hematopoietic progenitor cells. J Exp Med 177:1331-1342
12. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
13. Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, Han H, Kim H (2005) Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells. Stem Cells 23:584-593
14. Kroczek RA, Gunter KC, Seligmann B, Shevach EM (1986) Induction of T-cell activation by monoclonal anti-Thy1 antibodies. J Immunol 136:4379-4384
15. Kroczek RA, Gunter KC, Germain RN, Shevach EM (1986) Thy1 functions as a signal transduction molecule in T-lymphocytes and transfected B-lymphocytes. Nature 322:181-184
16. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97:14720-14725
17. Piper DR, Mujtaba T, Keyoung H, Roy NS, Goldman SA, Rao MS, Lucero MT (2000) Identification and characterization of neuronal precursors and their progeny from human fetal tissue. J Neurosci Res 66:356-368
18. Barnstable CJ, Drager UC (1984) Thy-1 antigen: a ganglion cell specific marker in the rodent retina. Neuroscience 11:847-855
19. Nash MS, Osborne NN (1999) Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci 40:1293-1298
20. Seeger RC, Danon YL, Rayner SA, Hoover H (1082) Detection of a Thy1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128:983-989
21. Kemshead JT, Heath L, Gibson FM, Katz F, Richmond F, Treleaven J, Ungestad J (1986) Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements, and observations. Br J Cancer 54:771-778
22. Buccisano F, Rossi FM, Venditti A, DelPoeta G, Cox MC, Abbruzzese E, Rupolo M, Berretta M, Degan M, Russo S, Tamburini A, Maurillo L et al (2004) CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias. Br J Haematol 125:203-212
23. Vitali R, Cesi V, Nicotra MR, Mc Dowell HP, Donfrancesco A, Mannarino O, Natali PG, Raschella G, Dominici C (2003) C-kit is preferentially expressed in mycn-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. Int J Cancer 106:147-152
24. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC (1994) Expression of stem cell factor and c-kit in human neuroblastoma. Blood 84:3465-3472
25. Tiveron MC, Barboni E, Pliego Rivero FB, Gormley AM, Seeley PJ, Grosveld F, Morris R (1992) Selective inhibition of neurite outgrowth on mature astrocytes by Thy1 glycoprotein. Nature 355:745-748